Cargando…
Screening for Activity Against AMPA Receptors Among Anticonvulsants—Focus on Phenytoin
The interest in AMPA receptors as a target for epilepsy treatment increased substantially after the approval of perampanel, a negative AMPA receptor allosteric antagonist, for the treatment of partial-onset seizures and generalized tonic-clonic seizures. Here we performed a screening for activity ag...
Autores principales: | Dron, M. Y., Zhigulin, A. S., Tikhonov, D. B., Barygin, O. I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688955/ https://www.ncbi.nlm.nih.gov/pubmed/34950035 http://dx.doi.org/10.3389/fphar.2021.775040 |
Ejemplares similares
-
Mechanisms of AMPA Receptor Inhibition by Diminazene
por: Zhigulin, A. S., et al.
Publicado: (2022) -
Reduced Effect of Anticonvulsants on AMPA Receptor Palmitoylation-Deficient Mice
por: Iizumi, Madoka, et al.
Publicado: (2021) -
Mechanisms of NMDA Receptor Inhibition by Sepimostat—Comparison with Nafamostat and Diarylamidine Compounds
por: Zhigulin, Arseniy S., et al.
Publicado: (2023) -
Febrile Seizures Cause a Rapid Depletion of Calcium-Permeable AMPA Receptors at the Synapses of Principal Neurons in the Entorhinal Cortex and Hippocampus of the Rat
por: Postnikova, Tatyana Y., et al.
Publicado: (2023) -
Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity—In Vitro and In Vivo Studies
por: Latacz, Gniewomir, et al.
Publicado: (2022)